The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon


Work +1 973 912 7100
Fax +1 973 912 7199

Jeffrey Baumel

Work +1 973 912 7189

Work Department

Venture Technology, Corporate/M&A


Global Head of Dentons' Health Care and Life Sciences sector team. Provides representation to a broad range of companies in connection with financing, M&A and corporate transactions, primarily in the life sciences, biotechnology and technology industries. Has substantial experience representing issuers, underwriters and placement agents in connection with public offerings and private placements of equity and debt securities. Experience also includes counseling private and public Boards of Directors in connection with corporate governance, compensation and securities law compliance issues.


Joined Dentons in 2008


•Biotechnology Industry Organization •Bio CEO & Investor Conference •Deloitte IPO Intensive Seminar •Mid-Atlantic Venture Conference


Cornell Law School, 1983, JD University of Rochester, 1980, BA, cum laude

United States: Industry focus

Healthcare: life sciences

Within: Healthcare: life sciences

At Dentons, the group advises a diverse range of clients in the pharmaceutical industry, including manufacturers, distributors and service providers. In New Jersey, group co-head Jeffrey Baumel, Ilan Katz and Ira Kotel led advice to PharmAthene on a $100m merger with Altimmune. Dallas-based Robert Hanson has been representing Monsanto in various patent matters, including opposition proceedings. The group is also headed by Stephanie Seidman in San Diego and Peg Donahue Hall in Dallas.

[back to top]

United States: M&A/corporate and commercial

Venture capital and emerging companies

Within: Venture capital and emerging companies

Dentons’ truly global venture capital and emerging companies practice has brought an additional pipeline of business to the US team. It now works on a number of venture capital financings for overseas companies, helps foreign emerging companies to establish a footprint in the US and advises US growth companies on establishing themselves overseas. The firm is well plugged into the start-up community and operates incubators in San Diego and Palo Alto. The firm is especially prominent in AI, fintech, cryptocurrency, mobile, life sciences and digital health, and has a large team primarily spread across its New York, Bay Area, San Diego and Los Angeles offices. It is the only international law firm to have a dedicated venture capital and emerging company office in New York’s Meatpacking District, a notable tech hub. It advised Operative Media on its $200m sale to SintecMedia, a Francisco Partners portfolio company. Other clients include DoubleVerify, Voxy, CommonBond and Zype. New York partner Victor Boyajian heads the department, and medical device expert John Cleary heads the Short Hills office in New Jersey where Jeffrey Baumel is recommended for life sciences.

[back to top]

Back to index

Legal Developments by:

  • Legal aspects of documenting shipping finance transactions in the United Arab Emirates

    The United Arab Emirates (UAE) is strategically placed between Europe and the Far East. The UAE has been ranked among the top 15 maritime nations by the United Nations Conference on Trade and Development and the UAE Government is working on plans to transform the shipping industry into one of the country’s major economic sectors.
    - SNR Denton

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to